계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Twist Bioscience
About
Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development.
- San Francisco,California,United States
- 501 - 1000
- http://www.twistbioscience.com
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $250M
- Industries
- Biotechnology,Chemical,Health Care,Life Science
- Founded date
- Jan 1, 2013
- Number Of Employee
- 501 - 1000
- Operating Status
- Active
- Stock Symbol
- nasdaq:TWST
- Legal Name
- Twist Bioscience Corporation
- Also Known As
- Twist
Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development. At Twist Bioscience Corporation, they work in the service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, their customers are developing ways to better lives and improve the sustainability of the planet. They believe that the faster their customers succeed, the better for all of them, and Twist Bioscience is uniquely positioned to help accelerate their efforts.Their innovative silicon-based DNA Synthesis Platform provides precision at a scale that we believe is otherwise unavailable to their customers. their platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead.Twist Bioscience was founded in 2013 and is headquartered in San Francisco, California.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 10, 2022 | Post-IPO Equity | $250M | — | — | — | Detail |
| Oct 30, 2018 | IPO | $70M | — | — | — | Detail |
| Apr 2, 2018 | Series Unknown | $50M | — | — | — | Detail |
| Jun 14, 2017 | Series Unknown | $27M | 8 |
Biomatics Capital Partners
|
— | Detail |
| Mar 27, 2017 | Series Unknown | $33M | 2 | — | — | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Apr 13, 2022
REV3AL
|
Series Unknown | — | Blockchain | — |
|
Jul 10, 2021
Banger
|
Series Unknown | — | Blockchain | — |
|
Jul 17, 2017
Sphere Fluidics
|
Grant | $1.25M | Biotechnology | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Biomatics Capital Partners
|
Yes | Series Unknown |
Illumina
|
Yes | Series C |
|
|
— | Series Unknown |
Bay City Capital
|
— | Series Unknown |
Ditch Plains Capital Management LP
|
— | Series Unknown |
FIS
|
— | Series Unknown |
Kangmei Pharmaceutical
|
— | Series Unknown |
|
|
— | Series Unknown |
Reinet Investments S.C.A.
|
— | Series Unknown |
Asset Management Ventures (AMV)
|
— | Series Unknown |
Employee Profiles
Acquisition
Twist Bioscience has acquired 3 organizations. Their most recent acquisition was Genome Compiler on Apr 6, 2016. They acquired Genome Compiler for 0.
